Skip to main content
Figure 1 | BMC Cardiovascular Disorders

Figure 1

From: Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: The peak of reactive cell proliferation as a hallmark for the duration of the treatment

Figure 1

Effect of simultaneous intra/extravascular administration of high dose diltiazem (50 μg/mL) for 1 – 7 days on time course of cells undergoing DNA synthesis in coronary organ cultures 7 (A) and 28 days (B) after ex vivo ballooning. The number of cells in the neointima with positive bromodeoxyuridine incorporation is depicted in relation to the total cell number.

Back to article page